Physician

Lauren Hall Mccaslin, MD

According to 2025 Medicare claims, Lauren Mccaslin, MD (NPI: 1205221629) practices dermatology in the Fayetteville-Springdale-Rogers, AR market, with the plurality of this provider's patient population coming from Benton, AR. This provider's primary affiliated billing organization is HULL DERMATOLOGY P.A. (NPI: 1407082464; TIN: 204390114) and primary practice location at 72758-8600.

Mccaslin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 698 traditional Medicare patients, billed 5,661 HCPCS/CPT codes, and received $551,148 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 940 prescription claims across 384 beneficiaries totaling $339,298 in drug costs, led by Taltz Autoinjector (Ixekizumab). Open Payments data shows 39 records totaling $785. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $53,882 to $551,148. Similarly, Part D prescription costs have risen steadily, from $11,693 to $339,298. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$276K$551K2019 Medicare payment: $53,882 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $147,923 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $268,500 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $280,016 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $529,191 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $551,148 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019207844$53,882
20204332,389$147,923
20215873,949$268,500
20226063,503$280,016
20236415,037$529,191
20246985,661$551,148

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$170K$339K2015 Drug cost: $11,693 (USD; Tot_Drug_Cst)2016 Drug cost: $97,842 (USD; Tot_Drug_Cst)2017 Drug cost: $121,494 (USD; Tot_Drug_Cst)2018 Drug cost: $306,453 (USD; Tot_Drug_Cst)2019 Drug cost: $36,706 (USD; Tot_Drug_Cst)2020 Drug cost: $63,727 (USD; Tot_Drug_Cst)2021 Drug cost: $139,389 (USD; Tot_Drug_Cst)2022 Drug cost: $150,817 (USD; Tot_Drug_Cst)2023 Drug cost: $152,009 (USD; Tot_Drug_Cst)2024 Drug cost: $339,298 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R28$11,693
201680187$97,842
2017112286$121,494
2018131318$306,453
2019134281$36,706
2020210494$63,727
2021290692$139,389
2022338841$150,817
2023339880$152,009
2024384940$339,298

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more185250$76
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more452697$58
11102Biopsy of related skin growth, first growth267355$58
17000Destruction of precancer skin growth, 1 growth310423$31
17003Destruction of precancer skin growth, 2-14 growths2602,026$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Taltz AutoinjectorIxekizumab24672$162,249
KetoconazoleKetoconazole1534,655$2,218
Clobetasol PropionateClobetasol Propionate521,474$2,101
TacrolimusTacrolimus12450$1,350
MetronidazoleMetronidazole21594$983

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.39$785ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Lauren Hall Mccaslin, MD?

Tedicare shows public-source Medicare data for Lauren Hall Mccaslin, MD (NPI 1205221629), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lauren Hall Mccaslin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Lauren Hall Mccaslin, MD?

Lauren Hall Mccaslin, MD is linked to HULL DERMATOLOGY P.A. (billing NPI 1407082464) in the available physician profile data.

Does Lauren Hall Mccaslin, MD have Open Payments data?

Lauren Hall Mccaslin, MD has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.